Impact of cancer on sexuality: How is the Moroccan patient affected?

Autor: Errihani, H., Elghissassi, I., Mellas, N., Belbaraka, R., Messmoudi, M., Kaikani, W.

Publikováno v: In Sexologies 2010 19(2):92-98

Knowledge and views of physicians and nurses about physical activity advice in oncology care: a cross-sectional study.

Autor: Azemmour Y; Clinical Research Biostatistics and Epidemiology Laboratory, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco., Boutayeb S; Translational Oncology Research Team, National Institute of Oncology, Ibn Sina University Hospital Center, Mohammed V University, Rabat, Morocco., Nafai S; Division of Occupational Therapy, School of Health Sciences, American International College, USA., Souadka A; Translational Oncology Research Team, National Institute of Oncology, Ibn Sina University Hospital Center, Mohammed V University, Rabat, Morocco., Mrabti H; Translational Oncology Research Team, National Institute of Oncology, Ibn Sina University Hospital Center, Mohammed V University, Rabat, Morocco., Elghissassi I; Translational Oncology Research Team, National Institute of Oncology, Ibn Sina University Hospital Center, Mohammed V University, Rabat, Morocco., Marfak A; National School of Public Health, Rabat, Morocco., Errihani H; Translational Oncology Research Team, National Institute of Oncology, Ibn Sina University Hospital Center, Mohammed V University, Rabat, Morocco.

Publikováno v: The Pan African medical journal [Pan Afr Med J] 2022 Jan 20; Vol. 41, pp. 57. Date of Electronic Publication: 2022 Jan 20 (Print Publication: 2022).

Frequency and types of EGFR mutations in Moroccan patients with non-small cell lung cancer.

Autor: Lemine Sow M; Department of Medical Oncology, National Institute of Oncology, Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, Morocco., El Yacoubi H; Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, Morocco., Moukafih B; Department of Medical Oncology, National Institute of Oncology, Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, Morocco., Balde S; Department of Medical Oncology, National Institute of Oncology, Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, Morocco., Akimana G; Department of Medical Oncology, National Institute of Oncology, Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, Morocco., Najem S; Department of Medical Oncology, National Institute of Oncology, Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, Morocco., El Khoyaali S; Department of Medical Oncology, National Institute of Oncology, Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, Morocco., Abahssain H; Department of Medical Oncology, National Institute of Oncology, Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, Morocco., Chaibi A; Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, Morocco., Zeb Khan S; Department of Clinical Oncology, BINOR Cancer Hospital, Bannu, Pakistan., Trapani D; Department of Oncology and Hematology, University of Milan.; Division of New Drug Development, European Institute of Oncology, Milan, Italy., Benzekri A; Department of Medical Oncology, National Institute of Oncology, Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, Morocco., Ghaouti M; Department of Medical Oncology, National Institute of Oncology, Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, Morocco., Gamra L; Department of Medical Oncology, National Institute of Oncology, Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, Morocco., Mestari A; Department of Medical Oncology, National Institute of Oncology, Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, Morocco., Kettani F; Department of Medical Oncology, National Institute of Oncology, Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, Morocco., Rahali Y; Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, Morocco., Mrabti H; Department of Medical Oncology, National Institute of Oncology, Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, Morocco., Elghissassi I; Department of Medical Oncology, National Institute of Oncology, Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, Morocco., Errihani H; Department of Medical Oncology, National Institute of Oncology, Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, Morocco.

Publikováno v: Tumori [Tumori] 2021 Aug; Vol. 107 (4), pp. 335-340. Date of Electronic Publication: 2020 Oct 20.

128P - Frequency and types of EGFR mutation in Moroccan patients with non-small cell lung cancer

Autor: Sow, M.L., El Yacoubi, H., Moukafih, B., Balde, S., Akimana, G., Elkhoyaali, S., Abahssain, H., Mrabti, H., Elghissassi, I., Errihani, H.

Publikováno v: In Annals of Oncology April 2019 30 Supplement 2:ii50-ii50

The Frequency and Specific Features of Rare Epidermal Growth Factor Receptor Mutations in Moroccan Patients with Lung Adenocarcinoma whose Tumors harbor positive EGFR mutations.

Autor: El Yacoubi H; Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco., Lemine Sow M; Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco., El Ghouti M; Department of Pathology, Nations-Unies Pathology Center, Rabat, Morocco., Kettani F; Department of Pathology, Nations-Unies Pathology Center, Rabat, Morocco., Gamra L; Department of Pathology, Hassan Pathology Center, Rabat, Morocco., Mestari A; Department of Pathology, Agdal Pathology Center, Rabat, Morocco., Jabri L; Department of Pathology, Casapath Pathology Center, Casablanca, Morocco., Elghissassi I; Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco., Errihani H; Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco.

Publikováno v: The Gulf journal of oncology [Gulf J Oncolog] 2020 May; Vol. 1 (33), pp. 40-44.